184 related articles for article (PubMed ID: 37740749)
1. Anticoagulants in adult extracorporeal membrane oxygenation: alternatives to standardized anticoagulation with unfractionated heparin.
Tang S; Xu L; Li H; Wu Z; Wen Q
Eur J Clin Pharmacol; 2023 Dec; 79(12):1583-1594. PubMed ID: 37740749
[TBL] [Abstract][Full Text] [Related]
2. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
[TBL] [Abstract][Full Text] [Related]
4. Intravenous enoxaparin as alternative ECMO anticoagulation over a period of 94 days: a case report.
Durila M; Berousek J; Vlasakova V; Vymazal T
J Cardiothorac Surg; 2023 Apr; 18(1):137. PubMed ID: 37041623
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support in pediatric patients: review of the literature and alternative anticoagulants.
Pollak U
Perfusion; 2018 May; 33(1_suppl):7-17. PubMed ID: 29788841
[TBL] [Abstract][Full Text] [Related]
6. Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO.
Carter KT; Kutcher ME; Shake JG; Panos AL; Cochran RP; Creswell LL; Copeland H
J Surg Res; 2019 Nov; 243():399-409. PubMed ID: 31277018
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
Fitousis K; Klasek R; Mason PE; Masud F
Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
[TBL] [Abstract][Full Text] [Related]
8. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
[TBL] [Abstract][Full Text] [Related]
10. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation: A systematic review.
Sanfilippo F; Currò JM; La Via L; Dezio V; Martucci G; Brancati S; Murabito P; Pappalardo F; Astuto M
Artif Organs; 2022 Dec; 46(12):2371-2381. PubMed ID: 35531906
[TBL] [Abstract][Full Text] [Related]
11. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants.
Pollak U
J Thromb Haemost; 2019 Oct; 17(10):1608-1622. PubMed ID: 31313454
[TBL] [Abstract][Full Text] [Related]
12. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
[TBL] [Abstract][Full Text] [Related]
14. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation.
Sheridan EA; Sekela ME; Pandya KA; Schadler A; Ather A
ASAIO J; 2022 Jul; 68(7):920-924. PubMed ID: 34669620
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
Hanna DJ; Torbic H; Militello M; Strnad K; Krishnan S; Hohlfelder B
Int J Artif Organs; 2022 Aug; 45(8):688-694. PubMed ID: 35708334
[TBL] [Abstract][Full Text] [Related]
17. Unfractionated Heparin Versus Subcutaneous Nadroparin in Adults Supported With Venovenous Extracorporeal Membrane Oxygenation: a Retrospective, Multicenter Study.
Piwowarczyk P; Borys M; Kutnik P; Szczukocka M; Sysiak-Sławecka J; Szułdrzyński K; Ligowski M; Drobiński D; Czarnik T; Czuczwar M
ASAIO J; 2021 Jan; 67(1):104-111. PubMed ID: 32404610
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal membrane oxygenation-hemostatic complications.
Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation Management during Extracorporeal Membrane Oxygenation-A Mini-Review.
Burša F; Sklienka P; Frelich M; Jor O; Ekrtová T; Máca J
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36556985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
